{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:56:03Z","timestamp":1793836563333,"version":"4.6.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022720","name":"Fondazione Regionale per la Ricerca Biomedica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2024.110230","type":"journal-article","created":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T22:43:34Z","timestamp":1710715414000},"page":"110230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2371-1227","authenticated-orcid":false,"given":"Maddalena","family":"Pavarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-5847","authenticated-orcid":false,"given":"Lisa","family":"Alborghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2974-2347","authenticated-orcid":false,"given":"Stefania","family":"Aimonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Maggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-5684","authenticated-orcid":false,"given":"Antonella","family":"Bianculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Petrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Ubeira-Gabellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Salmoiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-4506","authenticated-orcid":false,"given":"Barbara","family":"Avuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Giandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-8986","authenticated-orcid":false,"given":"Fernando","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sanguineti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Magdalena Waskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Rago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-6865","authenticated-orcid":false,"given":"Domenico","family":"Cante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Girelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Vavassori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Gisella","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-603X","authenticated-orcid":false,"given":"Tiziana","family":"Rancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-8196","authenticated-orcid":false,"given":"Cesare","family":"Cozzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-8494","authenticated-orcid":false,"given":"Claudio","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110230_b0005","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2024.110230_b0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2217\/fon-2021-0483","article-title":"A systematic review and meta-analysis of the impact of radiation-related lymphopenia on outcomes in pancreatic cancer","volume":"18","author":"Venkatesulu","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0035","doi-asserted-by":"crossref","first-page":"1201500","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Onc Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2014.09.002","article-title":"Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy","volume":"113","author":"Yang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0050","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2009.12.025","article-title":"Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT","volume":"79","author":"Albuquerque","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0055","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1002\/cam4.4131","article-title":"Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy","volume":"10","author":"Wang","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2024.110230_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.radonc.2019.12.008","article-title":"Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer","volume":"152","author":"Anderson","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0065","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3389\/fonc.2019.01488","article-title":"Prognosis and risk factors of radiation-induced lymphopenia in early-stage lung cancer treated with stereotactic body radiation therapy","volume":"9","author":"Zhao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmp.2016.03.003","article-title":"Predicting toxicity in radiotherapy for prostate cancer","volume":"32","author":"Landoni","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2024.110230_b0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/fon.13.237","article-title":"Hematologic changes during prostate cancer radiation therapy are dependent on the treatment volume","volume":"10","author":"Pinkawa","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0080","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic toxicity in patients treated with postprostatectomy whole-pelvis irradiation with different intensity modulated radiation therapy techniques is not negligible and is prolonged: preliminary results of a longitudinal, observational study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2015.11.020","article-title":"Dose\u2013volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation","volume":"118","author":"Sini","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijrobp.2023.07.036","article-title":"A dosimetric correlation between radiation dose to bone and reduction of hemoglobin levels after radiation therapy for prostate cancer","volume":"118","author":"Fenlon","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0095","article-title":"NTCP modeling and dose-volume correlations of significant hematocrit drops 3 months after prostate radiation therapy","volume":"9","author":"Papanikolaou","year":"2024","journal-title":"Adv Rad Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/07357907.2021.1960992","article-title":"A systematic review of radiation-related lymphopenia in genito-urinary malignancies","volume":"39","author":"Elumalai","year":"2021","journal-title":"Cancer Invest"},{"key":"10.1016\/j.radonc.2024.110230_b0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2022.02.030","article-title":"Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: a systematic review of the literature","volume":"170","author":"Danckaert","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.adro.2019.01.005","article-title":"Radiation-related lymphopenia after pelvic nodal irradiation for prostate cancer","volume":"4","author":"Schad","year":"2019","journal-title":"Adv Rad Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0115","first-page":"2803","article-title":"Hematologic toxicity of conformal radiotherapy and intensity modulated radiotherapy in prostate and bladder cancer patients","volume":"19","author":"Miszczyk","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.radonc.2024.110230_b0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41571-019-0238-9","article-title":"Assessing the interactions between radiotherapy and antitumour immunity","volume":"16","author":"Grassberger","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/2162402X.2018.1496881","article-title":"Impact of curative radiotherapy on the immune status of patients with localized prostate cancer","volume":"7","author":"Eckert","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.radonc.2024.110230_b0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.radonc.2024.110230_b0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.radonc.2024.110230_b0140","doi-asserted-by":"crossref","first-page":"26422","DOI":"10.18632\/oncotarget.8389","article-title":"Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2024.110230_b0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/CBM-210292","article-title":"Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer","volume":"34","author":"Yang","year":"2022","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.radonc.2024.110230_b0150","article-title":"Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.radonc.2019.03.008","article-title":"Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy","volume":"135","author":"Joseph","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2021.02.029","article-title":"Hematological toxicity in patients with solid malignant tumors treated with radiation \u2013 temporal analysis, dose response and impact on survival","volume":"158","author":"Terrones-Campos","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0170","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0175","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/1097-0142(197809)42:3<1057::AID-CNCR2820420304>3.0.CO;2-P","article-title":"Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time","volume":"42","author":"Sacks","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110230_b0180","first-page":"840","article-title":"Clinical status and rate of recovery of blood lymphocyte levels after radiotherapy for bladder cancer","volume":"39","author":"O'Toole","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2024.110230_b0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13014-021-01969-1","article-title":"Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy","volume":"16","author":"Reddy","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0190","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac4da4","article-title":"A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy","volume":"67","author":"Xing","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110230_b0195","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1002\/mp.15584","article-title":"A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy","volume":"49","author":"Ebrahimi","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.radonc.2024.110230_b0205","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110230_b0210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.radonc.2017.07.005","article-title":"Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: first quantification of bowel dose\u2013volume effects","volume":"124","author":"Sini","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0215","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3389\/fonc.2020.01207","article-title":"Predictors of 2-year incidence of patient-reported urinary incontinence after post-prostatectomy radiotherapy: evidence of dose and fractionation effects","volume":"10","author":"Bresolin","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0220","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.radonc.2021.02.026","article-title":"Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study","volume":"158","author":"Bresolin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0225","article-title":"TotalSegmentator: robust segmentation of 104 anatomic structures in CT images. radiology","author":"Wasserthal","year":"2023","journal-title":"Artif Intell"},{"key":"10.1016\/j.radonc.2024.110230_b0230","unstructured":"National Cancer Institute, National Institutes of Health, US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Published May 28, 2009; Revised version 4.03 June 14, 2010."},{"key":"10.1016\/j.radonc.2024.110230_b0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2014.02.006","article-title":"Relationships between bladder dose\u2013volume\/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer","volume":"111","author":"Carillo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0240","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2024.110230_b0245","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2022.08.001","article-title":"Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation","volume":"175","author":"Cozzarini","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110230_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2023.102644","article-title":"Bone marrow sparing in prostate cancer patients treated with post-operative pelvic nodal radiotherapy - a proton versus photon comparison","volume":"112","author":"De Ornelas","year":"2023","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2024.110230_b0255","doi-asserted-by":"crossref","first-page":"1119173","DOI":"10.3389\/fonc.2023.1119173","article-title":"Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: computational simulation based on circulating blood cells","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402400152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:38:35Z","timestamp":1741455515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402400152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":51,"alternative-id":["S016781402400152X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110230","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110230"}}